Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications
Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: June 22, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 16, 2025
Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma.
Journal: Current problems in cancer
Published: August 25, 2025
The comeback of orchiectomy in advanced prostate cancer- is that feasible?
Journal: Urologic oncology
Published: April 08, 2025
Formulation-Based Cost Savings With Cabozantinib Capsules.
Journal: JAMA oncology
Published: April 03, 2025
Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 02, 2025
A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: December 10, 2024
Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 09, 2024
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma.
Journal: Clinical and translational radiation oncology
Published: September 02, 2024
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Journal: The New England journal of medicine
Published: August 21, 2024
Last Updated: 09/26/2026